Mayne Pharma 2013 Annual Report GO
With established oral drug delivery experience and proprietary technologies, clients receive products that have developmental, regulatory and marketing exclusivity.
Mayne Pharma’s current range of proprietary products, products in the development pipeline and an impressive array of products available for license.
Integrating Mayne Pharma’s proprietary technologies, manufacturing capabilities and knowledge of product markets, to provide tailored pharmaceutical solutions.
Commercial contract manufacturing of oral products and commercial manufacture of in-house products for over 40 years at Mayne Pharmas’ GMP accredited facility.
Copyright © 2010 Mayne Pharma Group